108 related articles for article (PubMed ID: 31172491)
1. NADPH Oxidases and Aging Models of Lung Fibrosis.
Bernard K; Thannickal VJ
Methods Mol Biol; 2019; 1982():487-496. PubMed ID: 31172491
[TBL] [Abstract][Full Text] [Related]
2. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance.
Hecker L; Logsdon NJ; Kurundkar D; Kurundkar A; Bernard K; Hock T; Meldrum E; Sanders YY; Thannickal VJ
Sci Transl Med; 2014 Apr; 6(231):231ra47. PubMed ID: 24718857
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor β1 (TGFβ1)-induced CD44V6-NOX4 signaling in pathogenesis of idiopathic pulmonary fibrosis.
Ghatak S; Hascall VC; Markwald RR; Feghali-Bostwick C; Artlett CM; Gooz M; Bogatkevich GS; Atanelishvili I; Silver RM; Wood J; Thannickal VJ; Misra S
J Biol Chem; 2017 Jun; 292(25):10490-10519. PubMed ID: 28389561
[TBL] [Abstract][Full Text] [Related]
4. A key role for NOX4 in epithelial cell death during development of lung fibrosis.
Carnesecchi S; Deffert C; Donati Y; Basset O; Hinz B; Preynat-Seauve O; Guichard C; Arbiser JL; Banfi B; Pache JC; Barazzone-Argiroffo C; Krause KH
Antioxid Redox Signal; 2011 Aug; 15(3):607-19. PubMed ID: 21391892
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Hecker L; Vittal R; Jones T; Jagirdar R; Luckhardt TR; Horowitz JC; Pennathur S; Martinez FJ; Thannickal VJ
Nat Med; 2009 Sep; 15(9):1077-81. PubMed ID: 19701206
[TBL] [Abstract][Full Text] [Related]
6. An inhibitor of NADPH oxidase-4 attenuates established pulmonary fibrosis in a rodent disease model.
Jarman ER; Khambata VS; Cope C; Jones P; Roger J; Ye LY; Duggan N; Head D; Pearce A; Press NJ; Bellenie B; Sohal B; Jarai G
Am J Respir Cell Mol Biol; 2014 Jan; 50(1):158-69. PubMed ID: 23977848
[TBL] [Abstract][Full Text] [Related]
7. Forefront: MiR-34a-Knockout Mice with Wild Type Hematopoietic Cells, Retain Persistent Fibrosis Following Lung Injury.
Bulvik R; Biton M; Berkman N; Breuer R; Wallach-Dayan SB
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32210149
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin attenuates myofibroblast differentiation and lung fibrosis development through proteasomal degradation of NOX4.
Tsubouchi K; Araya J; Minagawa S; Hara H; Ichikawa A; Saito N; Kadota T; Sato N; Yoshida M; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Yanagisawa H; Hashimoto M; Wakui H; Yoshii Y; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nakayama K; Nakanishi Y; Kuwano K
Autophagy; 2017 Aug; 13(8):1420-1434. PubMed ID: 28613983
[TBL] [Abstract][Full Text] [Related]
9. Redox Imbalance in Idiopathic Pulmonary Fibrosis: A Role for Oxidant Cross-Talk Between NADPH Oxidase Enzymes and Mitochondria.
Veith C; Boots AW; Idris M; van Schooten FJ; van der Vliet A
Antioxid Redox Signal; 2019 Nov; 31(14):1092-1115. PubMed ID: 30793932
[No Abstract] [Full Text] [Related]
10. Dysregulated Nox4 ubiquitination contributes to redox imbalance and age-related severity of acute lung injury.
Palumbo S; Shin YJ; Ahmad K; Desai AA; Quijada H; Mohamed M; Knox A; Sammani S; Colson BA; Wang T; Garcia JG; Hecker L
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L297-L308. PubMed ID: 28062482
[TBL] [Abstract][Full Text] [Related]
11. Metformin attenuates lung fibrosis development via NOX4 suppression.
Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
[TBL] [Abstract][Full Text] [Related]
12. Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis.
Dosoki H; Stegemann A; Taha M; Schnittler H; Luger TA; Schröder K; Distler JH; Kerkhoff C; Böhm M
Exp Dermatol; 2017 Jan; 26(1):73-81. PubMed ID: 27576129
[TBL] [Abstract][Full Text] [Related]
13. The NADPH oxidase Nox4 and aging in the heart.
Ago T; Matsushima S; Kuroda J; Zablocki D; Kitazono T; Sadoshima J
Aging (Albany NY); 2010 Dec; 2(12):1012-6. PubMed ID: 21212466
[TBL] [Abstract][Full Text] [Related]
14. NADPH oxidase-mediated induction of reactive oxygen species and extracellular matrix deposition by insulin-like growth factor binding protein-5.
Yasuoka H; Garrett SM; Nguyen XX; Artlett CM; Feghali-Bostwick CA
Am J Physiol Lung Cell Mol Physiol; 2019 Apr; 316(4):L644-L655. PubMed ID: 30810066
[TBL] [Abstract][Full Text] [Related]
15. NADPH oxidases: Pathophysiology and therapeutic potential in age-associated pulmonary fibrosis.
Kato K; Hecker L
Redox Biol; 2020 Jun; 33():101541. PubMed ID: 32360174
[TBL] [Abstract][Full Text] [Related]
16. Aging, antagonistic pleiotropy and fibrotic disease.
Thannickal VJ
Int J Biochem Cell Biol; 2010 Sep; 42(9):1398-400. PubMed ID: 20595011
[TBL] [Abstract][Full Text] [Related]
17. Mammalian NADPH Oxidases.
Buvelot H; Jaquet V; Krause KH
Methods Mol Biol; 2019; 1982():17-36. PubMed ID: 31172464
[TBL] [Abstract][Full Text] [Related]
18. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
[TBL] [Abstract][Full Text] [Related]
19. Role of NADPH oxidases in the redox biology of liver fibrosis.
Crosas-Molist E; Fabregat I
Redox Biol; 2015 Dec; 6():106-111. PubMed ID: 26204504
[TBL] [Abstract][Full Text] [Related]
20. NAD(P)H oxidase 4 mediates transforming growth factor-beta1-induced differentiation of cardiac fibroblasts into myofibroblasts.
Cucoranu I; Clempus R; Dikalova A; Phelan PJ; Ariyan S; Dikalov S; Sorescu D
Circ Res; 2005 Oct; 97(9):900-7. PubMed ID: 16179589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
